Primary Aesthetic Breast Augmentation: Comparative Study Between Breast Implants and Autograft of Adipose Tissue
AMEP
1 other identifier
observational
119
1 country
1
Brief Summary
The use of autograft of adipose tissue for aesthetic breast augmentation is increasing year after year. According to the latest meta-analysis of 2016, autograft of adipose tissue in augmentation mastoplasty seems to be a promising method with a satisfactory resorption volume and patient and surgeon satisfaction. However, this technique allows for small to moderate breast augmentation and is therefore not suitable for patients wanting a significant increase. Breast prostheses allow a significant increase. Numerous studies have shown an improvement in patient satisfaction and quality of life assessed using the BREAST-Q questionnaire. On the other hand, very few studies have objectively evaluated the satisfaction of patients who have benefited from an autograft of adipose tissue as part of aesthetic breast augmentation. No study has yet compared the satisfaction of patients who have benefited from breast implants or lipofilling. The aim of this study is to compare the satisfaction of patients who have benefited from breast augmentation by prosthesis or by lipofilling using a remote satisfaction interview.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2024
CompletedNovember 27, 2023
October 1, 2023
7 months
October 26, 2023
November 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient woman satisfaction
This satisfaction will be assessed using a remote satisfaction interview
1 to 4 years after breast implants
Eligibility Criteria
Adult woman (age ≥ 18 years) having benefited from primary aesthetic breast augmentation at Strasbourg University Hospital between June 27, 2017 and June 27, 2022
You may qualify if:
- Adult woman (age ≥ 18 years)
- having benefited from primary aesthetic breast augmentation at Strasbourg University Hospital between June 27, 2017 and June 27, 2022
- not opposing the reuse of its data for scientific research purposes.
You may not qualify if:
- Woman who expressed her opposition to the reuse of her data for scientific research purposes
- Woman with a breast malformation: tuberous breasts or breast asymmetry of more than one cup
- Woman with comprehension difficulties
- Woman under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Chirurgie Plastique, Reconstructrice et Esthétique - CHU de Strasbourg - France
Strasbourg, 67091, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 27, 2023
Study Start
June 1, 2023
Primary Completion
January 1, 2024
Study Completion
January 22, 2024
Last Updated
November 27, 2023
Record last verified: 2023-10